Full Text View
Tabular View
No Study Results Posted
Related Studies
Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease (PC)
This study has been completed.
First Received: May 22, 2007   Last Updated: March 10, 2009   History of Changes
Sponsors and Collaborators: University of Wisconsin, Madison
Department of Veterans Affairs
Information provided by: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00478166
  Purpose

The purpose of this study is to use fMRI techniques to explore a certain part of the brain associated with Alzheimer's disease known as the posterior cingulate. Determining the functionality of this brain region may help us diagnose AD more accurately, thus allowing earlier treatment.


Condition
Magnetic Resonance Imaging
Alzheimer's Disease
Dementia
Adult Children
Risk

Genetics Home Reference related topics: Alzheimer disease
MedlinePlus related topics: Alzheimer's Disease Dementia MRI Scans
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment: 206
Study Start Date: July 2005
Study Completion Date: October 2007
Detailed Description:

The posterior cingulate is a key brain region suggested by recent studies to be affected in people at risk for Alzheimer's Disease (AD). Because the PC is affected very early in the course of AD and the region may have reduced function even prior to the onset of symptoms, further understanding of its functional role and its relationship to other brain regions may be helpful in detecting AD earlier and in monitoring disease progression and treatment.

This project examines the role of the PC and its connections to other brain regions using functional magnetic resonance imaging (fMRI), a technique that allows us to examine the brain at work during tests of memory and decision-making. The main goal is to see if functional connections between brain regions are modulated by risk for AD.

  Eligibility

Ages Eligible for Study:   55 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Cognitively healthy
  • (Controls Only) Parents survived past age 70 and did/do not have memory problems.

Exclusion Criteria:

  • Claustrophobia
  • Metallic or electronic implants
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00478166

Locations
United States, Wisconsin
University of Wisconsin - Wisconsin Comprehensive Memory Program
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Sterling C Johnson, PhD University of Wisconsin/VA GRECC
  More Information

Additional Information:
No publications provided

Responsible Party: University of Wisconsin - Madison ( Sterling Johnson, PhD )
Study ID Numbers: 2004-174
Study First Received: May 22, 2007
Last Updated: March 10, 2009
ClinicalTrials.gov Identifier: NCT00478166     History of Changes
Health Authority: United States: Institutional Review Board;   United States: Federal Government

Study placed in the following topic categories:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Alzheimer Disease
Central Nervous System Diseases
Neurodegenerative Diseases
Brain Diseases
Dementia
Cognition Disorders
Delirium

Additional relevant MeSH terms:
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Alzheimer Disease
Central Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Brain Diseases
Dementia

ClinicalTrials.gov processed this record on May 07, 2009